Health Canada
Symbol of the Government of Canada
Drugs and Health Products

Scientific Advisory Panel on Bioequivalence Requirements for Gender-Specific Drug Products (SAP-GSDP)

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Agenda

Place: Holland Cross, Tower B, Room 2000
Date and Time: June 2nd, 2011 at 2:00pm to 4:00pm

Chairperson: Dr. Jake Thiessen
Science Advisor: Dr. Conrad Pereira
Science and Regulatory Officer: Caroline Hunt
Participants: SAP-GSDP members, Health Canada

1. Opening remarks
Director General, Therapeutic Products Directorate
2. Affiliations and Interests / Review of Agenda
Chair
3. Acceptance of Terms of Reference
SAP-GSDP members
4. Deliberations and Answers to General Questions
SAP-GSDP members
 
  • Deliberations and Answers to Question 1
  • Deliberations and Answers to Question 2
  • Deliberations and Answers to Question 3
5. Closing Remarks and Adjournment of Meeting
Chair